U.S. License Holder:
Allergan
Date of License:
August-27-2009
Last Update:
Dec-15-2024
FDA-Approved Indications
ZENPEP (pancrelipase (amylase; lipase; protease)) is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.